Health Care & Life Sciences » Pharmaceuticals | Proteomics International Laboratories Ltd.

Proteomics International Laboratories Ltd. | Balance Sheet

Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Cash & Short Term Investments
51.00
2,005.00
878.40
1,232.80
2,316.80
Total Accounts Receivable
214.40
195.80
713.60
1,108.60
1,447.40
Other Current Assets
109.50
321.50
9.10
35.50
27.60
Total Current Assets
374.90
2,522.20
1,601.10
2,376.90
3,791.80
Net Property, Plant & Equipment
15.40
9.10
20.50
511.20
364.00
Total Investments and Advances
-
-
-
-
1,337.90
Intangible Assets
-
1.00
1.00
1.00
1.00
Other Assets
1.00
-
-
-
-
Total Assets
391.30
2,532.30
1,622.60
2,889.20
5,494.70
ST Debt & Current Portion LT Debt
575.00
-
-
219.20
147.50
Accounts Payable
199.40
82.40
125.40
135.90
125.90
Other Current Liabilities
79.20
192.60
242.40
223.70
337.80
Total Current Liabilities
853.70
275.00
367.70
578.80
611.10
Long-Term Debt
441.90
441.90
441.90
656.20
164.90
Provision for Risks & Charges
-
10.10
21.50
44.30
42.20
Total Liabilities
1,295.60
727.00
831.20
1,279.30
818.30
Common Equity (Total)
904.30
1,805.30
791.40
1,609.90
4,676.40
Total Shareholders' Equity
904.30
1,805.30
791.40
1,609.90
4,676.40
Total Equity
904.30
1,805.30
791.40
1,609.90
4,676.40
Liabilities & Shareholders' Equity
391.30
2,532.30
1,622.60
2,889.20
5,494.70

About Proteomics International Laboratories

View Profile
Address
QEII Medical Centre
Perth Western Australia (WA) 6009
Australia
Employees -
Website http://www.proteomics.com.au
Updated 07/08/2019
Proteomics International Laboratories Ltd. is a biological research and drug discovery company. It operates through three synergistic business units: Analytical services, Diagnostics and Therapeutics. The Analytical services unit engages in contract research, analytical testing and consultancy.